Synthesis and biological evaluation of a new series of sterols as potential hypocholesterolemic agents.
A new series of sterols was synthesized and tested in a CHO cell-based LDL receptor/luciferase (LDLR/Luc) assay to investigate the capability of derepressing the transcription of LDL receptor promoter in the presence of 25-hydroxycholesterol. The effect of various substitutions on antagonizing the repressing effect mediated by 25-hydroxycholesterol was also studied in terms of regio- and stereochemistry, lipophilicity, steric bulk, and pi-electron density. Except 12, compounds active in the primary LDLR/Luc assay were not active in the secondary simian virus 40/luciferase (SV40/Luc) assay, demonstrating the specificity of their in vitro activity. Eight active compounds of various structural types were selected and screened in a [1-14C-acetate]cholesterol biosynthesis inhibition assay; none has shown any interference with the cholesterol biosynthesis in CHO cells. In hypercholesterolemic hamsters, generally, compounds that were active in vitro were active in vivo and vice versa, with the exception of three in vitro inactive compounds: 3 beta-ols 3a' and 3c' as well as 3-ketone 2a. Experimental results from the livers of hamsters revealed that the in vivo conversion of 3a' or 2a to 3a has in part contributed to the observed in vivo activity, and it is also anticipated that 3c' may similarly be converted to 3c in hamsters.
Lin
H S
HS
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
Rampersaud
A A
AA
Archer
R A
RA
Pawlak
J M
JM
Beavers
L S
LS
Schmidt
R J
RJ
Kauffman
R F
RF
Bensch
W R
WR
Bumol
T F
TF
Apelgren
L D
LD
D000818:Animals; D000924:Anticholesteremic Agents; D016466:CHO Cells; D006224:Cricetinae; D006888:Hydroxycholesterols / Q000494:pharmacology; D008148:Lovastatin; D008647:Mesocricetus; D011401:Promoter Regions, Genetic; D011973:Receptors, LDL / Q000235:genetics*; D013261:Sterols / Q000138:chemical synthesis* / Q000494:pharmacology*; D014158:Transcription, Genetic / Q000187:drug effects
D000924:Anticholesteremic Agents; D006888:Hydroxycholesterols; D011973:Receptors, LDL; D013261:Sterols; C007997:25-hydroxycholesterol; D008148:Lovastatin